Literature DB >> 20981210

Sacroiliitis is common in Crohn's disease patients with perianal or upper gastrointestinal involvement.

Young Hwangbo1, Hyo Jong Kim, Ji Seon Park, Kyung Nam Ryu, Nam Hoon Kim, Jaejun Shim, Jae Young Jang, Seok Ho Dong, Byung Ho Kim, Young Woon Chang, Rin Chang.   

Abstract

BACKGROUND/AIMS: Sacroiliitis (SI) is one of the most frequent extraintestinal manifestations in inflammatory bowel disease (IBD) patients, but the exact prevalence has not been evaluated in Asia. There are few data on the association between SI and other clinical features of IBD. The prevalence of SI was evaluated using computed tomography (CT) and the phenotypic parameters associated with SI in Korean IBD patients were determined.
METHODS: Eighty-two patients with ulcerative colitis (UC) and 81 patients with Crohn's disease (CD) were evaluated clinically. The presence of SI was evaluated using bone window setting of abdomino-pelvic CT images by two radiologists.
RESULTS: The prevalence rates of SI were 12.2% and 21.0% in the UC and CD groups, respectively. There was no relationship between the localization or extent of intestinal inflammation and the presence of SI in the UC group. Multivariate analyses confirmed that perianal and upper-gastrointestinal (from the mouth through to the jejunum) diseases were associated with the occurrence of SI in the CD group (p=0.026 and p=0.047, respectively).
CONCLUSIONS: SI was as common among Korean IBD patients as among Western patients. Perianal or upper-gastrointestinal involvement is associated with SI in CD patients.

Entities:  

Keywords:  Extraintestinal manifestation; Inflammatory bowel disease; Prevalence; Sacroiliitis

Year:  2010        PMID: 20981210      PMCID: PMC2956345          DOI: 10.5009/gnl.2010.4.3.338

Source DB:  PubMed          Journal:  Gut Liver        ISSN: 1976-2283            Impact factor:   4.519


  27 in total

1.  Increase in lymphoid follicles and leukocyte adhesion molecules emphasizes a role for the gut in spondyloarthropathy pathogenesis.

Authors:  P Demetter; J A Van Huysse; F De Keyser; N Van Damme; G Verbruggen; H Mielants; M De Vos; E M Veys; C A Cuvelier
Journal:  J Pathol       Date:  2002-12       Impact factor: 7.996

2.  Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology.

Authors:  Mark S Silverberg; Jack Satsangi; Tariq Ahmad; Ian D R Arnott; Charles N Bernstein; Steven R Brant; Renzo Caprilli; Jean-Frédéric Colombel; Christoph Gasche; Karel Geboes; Derek P Jewell; Amir Karban; Edward V Loftus; A Salvador Peña; Robert H Riddell; David B Sachar; Stefan Schreiber; A Hillary Steinhart; Stephan R Targan; Severine Vermeire; B F Warren
Journal:  Can J Gastroenterol       Date:  2005-09       Impact factor: 3.522

3.  Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan city, central China.

Authors:  Li Jiang; Bing Xia; Jin Li; Mei Ye; Wenjuan Yan; Changsheng Deng; Yijuan Ding; Hesheng Luo; Wei Hou; Qiu Zhao; Nanzhi Liu; Hongyu Ren; Xiaohua Hou; Hualin Xu
Journal:  Inflamm Bowel Dis       Date:  2006-03       Impact factor: 5.325

4.  Extraintestinal manifestations of idiopathic ulcerative colitis.

Authors:  R Kochhar; S K Mehta; B Nagi; V Bhatia; M K Goenka; A K Malik
Journal:  Indian J Gastroenterol       Date:  1991-07

5.  The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study.

Authors:  C N Bernstein; J F Blanchard; P Rawsthorne; N Yu
Journal:  Am J Gastroenterol       Date:  2001-04       Impact factor: 10.864

6.  Asymptomatic sacroiliitis in inflammatory bowel disease. Assessment by computed tomography.

Authors:  N McEniff; S Eustace; C McCarthy; M O'Malley; C A O'Morain; S Hamilton
Journal:  Clin Imaging       Date:  1995 Oct-Dec       Impact factor: 1.605

7.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

8.  The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications.

Authors:  J Satsangi; M S Silverberg; S Vermeire; J-F Colombel
Journal:  Gut       Date:  2006-06       Impact factor: 23.059

9.  Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association.

Authors:  K de Vlam; H Mielants; C Cuvelier; F De Keyser; E M Veys; M De Vos
Journal:  J Rheumatol       Date:  2000-12       Impact factor: 4.666

10.  Macroscopic and microscopic gut lesions in seronegative spondyloarthropathies.

Authors:  G Simenon; A Van Gossum; M Adler; F Rickaert; T Appelboom
Journal:  J Rheumatol       Date:  1990-11       Impact factor: 4.666

View more
  6 in total

1.  Inflammatory bowel disease associated arthropathy.

Authors:  Sheila L Arvikar; Mark C Fisher
Journal:  Curr Rev Musculoskelet Med       Date:  2011-09

2.  Extraintestinal manifestations in inflammatory bowel disease: Prevalence and predictors in Indian patients.

Authors:  Debottam Bandyopadhyay; Sanjay Bandyopadhyay; Parasar Ghosh; Abhishek De; Anupam Bhattacharya; G K Dhali; Kshaunish Das
Journal:  Indian J Gastroenterol       Date:  2015-11-28

Review 3.  Prevalence of axial spondyloarthritis in patients with inflammatory bowel disease using cross-sectional imaging: a systematic literature review.

Authors:  Jobie Evans; Mark Sapsford; Scott McDonald; Kenneth Poole; Tim Raine; Deepak R Jadon
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-03-11       Impact factor: 5.346

4.  Sacroiliac joint involvement in children with inflammatory bowel diseases.

Authors:  Nelgin Gerenli; Betul Sozeri; Sevinc Kalin; Heves Kirmizibekmez; Coskun Celtik
Journal:  North Clin Istanb       Date:  2021-02-08

5.  Subclinical sacroiliitis detected by abdominopelvic computed tomography in Korean patients with Crohn's disease.

Authors:  You-Jung Ha; Hyo Jin Kim; Eugene Lee; Ji Hye Park; Young Soo Park; Yun Jong Lee; Yusuhn Kang; Hyuk Yoon
Journal:  Korean J Intern Med       Date:  2021-03-22       Impact factor: 2.884

6.  Temporal Relationship of Extraintestinal Manifestations in Inflammatory Bowel Disease.

Authors:  Istvan Fedor; Eva Zold; Zsolt Barta
Journal:  J Clin Med       Date:  2021-12-20       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.